Introducing Gluetacs Therapeutics to the UK Market
Gluetacs Therapeutics (www.gluetacs.com), a pioneering biotech company located in the innovative Lin-gang Special Area of China (Shanghai) Pilot Free Trade Zone, is making significant strides in the field of targeted protein degradation, both in molecular glue (GLUE) and bifunctional degrader (GLUETAC). As a member of the Lingang Cambridge Network, Gluetacs is committed to advancing its […]